Recovery Roll-on Gel
Product Images NDC 72683-008

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Recovery Roll-on (NDC 72683-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proximity Capital Partners Llc Dba Asutra, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Asutra Recovery Roll On Print Page 001)

Drug Facts panel for Recovery Roll-On 5% Menthol + 5% Camphor topical analgesic gel. Covers active ingredients and their purpose, uses for temporary relief of minor muscle and joint aches, warnings including external use only and avoidance of eyes and mucous membranes, directions to stop use and consult a doctor if symptoms worsen or persist, and precautions for pregnant or breast-feeding individuals. Also displays cruelty-free and vegan symbols and a barcode.*

FDA Label Image

2 (Asutra Recovery Roll On Print Page 002)

Drug Facts label panel for Recovery Roll-On topical gel lists directions for use by adults and children, other storage and safety information, inactive ingredients including water and oils, and additional ingredients like hydroxyacetophenone and tocopheryl acetate. It includes contact information for questions and details about FDA listing, distribution by Asutra in Chicago, and manufacturing by Waratekls Kft in Budapest, Hungary.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.